Skip to content

Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients

Artificial Intelligence Based on Machine Learning in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05751538
Enrollment
730
Registered
2023-03-02
Start date
2023-03-01
Completion date
2023-12-30
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Keywords

Bronchiectasis, Machine Learning, Artificial Intelligence

Brief summary

Bronchiectasis is a chronic respiratory disease characterized by permanent bronchiectasis.The incidence and prevalence of bronchiectasis have assumed continuously grows in global. Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural disease in vivo. However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility. Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.

Interventions

OTHERNo intervention

No intervention

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with bronchiectasis (according to the Chinese consensus, patient's previous chest CT examination must show bronchiectasis)

Exclusion criteria

* Patients with CT data and medical records missing

Design outcomes

Primary

MeasureTime frameDescription
Correlations of the artificial intelligence-driven scores with manual scoresFrom date of inclusion until the date of final quantification, assessed up to 12 monthsCorrelations and comparisons of the artificial intelligence-driven scores with manual scores by thoracic radiologists on CT scans of bronchiectasis patients.

Secondary

MeasureTime frameDescription
Correlation of the artificial intelligence-driven scores with pulmonary function testFrom date of inclusion until the date of final quantification, assessed up to 12 monthsCorrelation of quantitative measurement with pulmonary function

Countries

China

Contacts

Primary ContactJieming Qu
jmqu0906@163.com86-021-64370045

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026